TABLE 3.

COST-EFFECTIVENESS RATIOS FOR OTHER PROCEDURES IN THORACIC SURGERY

Procedure	Cost-Effectiveness Ratios (in 2002 dollars per quality-adjusted life-year gained)
Coronary artery bypass surgery	8,300–64,000*
Lung transplantation	133,000–216,000†
Heart transplantation compared with medical therapy	65,000‡
Implantable cardioverter defibrillator for survivors of cardiac arrest with a low cardiac ejection fraction	47,000§

^*Pliskin JS, Stason WB, Weinstein MC, Cohn PF, McEnany MT, Braun P. Coronary artery bypass graft surgery: clinical decision making and cost-effectiveness analysis. Med Decis Making 1981;1:10–28. Weinstein MC, Stason WB. Cost-effectiveness of coronary artery bypass surgery. Circulation 1982;66:III56–66. Harvard Center for Risk Analysis. The CEA registry: standardizing the methods and practices of cost-effectiveness analysis. Available from: http://www.hsph.harvard.edu/cearegistry/ (accessed February 13, 2002).

^†Ramsey SD, Patrick DL, Albert RK, Larson EB, Wood DE, Raghu G. The cost-effectiveness of lung transplantation: a pilot study. University of Washington Medical Center Lung Transplant Study Group. Chest 1995;108:1594–1601. Al MJ, Koopmanschap MA, van Enckevort PJ, Geertsma A, van der Bij W, de Boer WJ, TenVergert EM. Cost-effectiveness of lung transplantation in The Netherlands: a scenario analysis. Chest 1998;113:124–130.

^‡van Hout B, Bonsel G, Habbema D, van der Maas P, de Charro F. Heart transplantation in the Netherlands; costs, effects and scenarios. J Health Econ 1993;12:73–93.

^§Harvard Center for Risk Analysis. The CEA registry: standardizing the methods and practices of cost-effectiveness analysis. Available from: http://www.hsph.harvard.edu/cearegistry/ (accessed February 13, 2002). Owens DK, Sanders GD, Harris RA, McDonald KM, Heidenreich PA, Dembitzer AD, Hlatky MA. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med 1997;126:1–12.